Sabby Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-186
Closed -$1.51M 60
2025
Q1
$1.51M Buy
+186
New +$155K 4.44% 6
2017
Q1
Sell
-4,043
Closed -$29.7M 288
2016
Q4
$29.7M Sell
4,043
-855
-17% -$63.7K 1.73% 16
2016
Q3
$39.3M Buy
4,898
+7
+0.1% +$560 1.47% 12
2016
Q2
$38.5M Buy
4,891
+88
+2% +$6.63K 2.01% 11
2016
Q1
$34.6M Buy
4,803
+1,999
+71% +$151K 1.73% 11
2015
Q4
$23.6M Buy
2,804
+366
+15% +$30.4K 1.3% 12
2015
Q3
$20.4M Buy
2,438
+10
+0.4% +$844 0.84% 21
2015
Q2
$20.3M Buy
2,428
+2,268
+1,418% +$173K 0.74% 27
2015
Q1
$1.16M Buy
+160
New +$11.4K 0.05% 181
2014
Q1
Sell
-407
Closed -$2.08M 261
2013
Q4
$2.08M Hold
407
0.13% 86
2013
Q3
$2.05M Hold
407
0.13% 83
2013
Q2
$2M Buy
+407
New +$22.1K 0.13% 93

Other funds holding LLY

Sabby Management's LLY Position: Q2 2025 in Review

Sabby Management sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 3,420 shares — an estimated $2.82M sold.

Sabby Management first reported a position in LLY in Q2 2013 and held it in 5 quarters. The position peaked at $15.7M in Q4 2016. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Sabby Management reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Sabby Management sold 3,420 Eli Lilly shares in Q2 2025, an estimated $2.82M.
  • Sabby Management first reported a position in Eli Lilly in Q2 2013 and held it in 5 quarters.
  • Sabby Management's Eli Lilly position peaked at $15.7M in Q4 2016.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Sabby Management's 13F filing for Q2 2025, filed 14 Aug 2025.